A b s t r a c t
Granular cell tumors (GCTs) are predominantly benign neoplasms characterized by large polygonal tumor cells with abundant granular cytoplasm and relatively small nuclei. 1 The tumor cells typically grow in sheets or nests and tend to be poorly circumscribed. Abrikossoff 2 originally described GCTs in 1926. This and subsequent studies pointed to a muscular differentiation of these tumors. [2] [3] [4] However, this view has changed gradually during the last few decades. The findings of close anatomic relationship of these tumors with nerves; the ultrastructural demonstration of myelin figures, axon-like structures, and basal laminae; and the immunohistochemical reactivity with S-100 protein, neuron-specific enolase, and myelin proteins have strongly suggested a neural origin or differentiation. [5] [6] [7] [8] [9] [10] [11] [12] The most common sites of GCTs are the skin and tongue. However, they can be found in virtually any organ. A correct diagnosis generally can be made based on the characteristic histologic features. However, in some cases, especially in unusual sites, they may pose a diagnostic challenge. Immunohistochemical staining for S-100 protein has been used widely as an adjuvant marker in differential diagnosis. Since S-100 is present in many other cell types, positive staining in certain cases may not be helpful. The alpha-subunit of inhibin and calretinin are 2 other potential but not well-studied markers for GCTs. The present study evaluated the expression of the alpha-subunit of inhibin and calretinin in GCTs to determine their usefulness as diagnostic markers and to further investigate the histogenesis of these tumors.
Bronx, NY. Formalin-fixed, paraffin-embedded tissue sections were stained immunohistochemically with antibodies to S-100 protein, calretinin, and the alpha-subunit of inhibin. All sections were deparaffinized, rehydrated, and quenched with hydrogen peroxide. Antigen retrieval was performed as follows: for S-100 and calretinin stains, slides were incubated with DAKO Epitope Buffer (DAKO, Carpinteria, CA); and for the alpha-subunit of inhibin, with DAKO High pH Buffer (DAKO) in a steam bath at 95°C for 45 minutes. After equilibration in phosphate-buffered saline for 15 minutes, the slides were placed in an autostainer (DAKO) and incubated with antibodies to S-100 protein (polyclonal, 1:4,000 dilution; DAKO), calretinin (polyclonal, 1:50 dilution; Zymed, San Francisco, CA), and the alpha-subunit of inhibin (monoclonal, 1:25 dilution, Cell Marque, Austin, TX). Immunoreactivity was detected using DAKO EnVision methods (DAKO) according to the manufacturer's recommended procedures. For negative controls, slides were treated with the same procedures, including antigen retrieval, except for the replacement of primary antibodies with a negative diluent (Zymed). Immunoreactivity was graded according to staining intensity (-, negative; +, weak; ++, moderate; +++, strong) and extent (focal, <50% of tumor cells; diffuse, 50% or more tumor cells).
Results
We studied 43 cases of adult GCT. The tumors arose in a variety of organs, including skin (13 cases), soft tissue (10 cases), breast (7 cases), vulva (5 cases), tongue (4 cases), and esophagus, stomach, cystic duct, and vocal cord (1 case each). Histologically, all tumors were composed of large polygonal cells with abundant granular cytoplasm and small nuclei growing in sheets and nests, often interdigitating with surrounding fibrous connective tissue and skeletal muscle fibers. In 13 cases, pseudoepitheliomatous hyperplasia was observed in the overlying squamous mucosa or skin ❚Image 1A❚.
For each tissue section stained with antibody to S-100 protein, calretinin, and the alpha-subunit of inhibin, a paired negative control was conducted in the absence of primary antibody. Staining was absent in all negative controls. The results are summarized in ❚Table 1❚.
All cases showed moderate to strong diffuse staining for both S-100 protein and the alpha-subunit of inhibin ❚Image 2A❚ and ❚Image 2B❚. For S-100, both cytoplasmic and nuclear stains were observed, and for inhibin, only cytoplasmic staining was present. Of 43 cases, 40 (93%) were positive for calretinin, ranging from focal weak to diffuse strong staining. Both cytoplasmic and nuclear stains for calretinin were noted. Of the 40 positive cases, 21 showed diffuse moderate to strong (++ and +++) ❚Image 2C❚, 3 diffuse weak (+), and 11 focal weak to moderate (+ and ++) staining. In 5 cases, positive staining for calretinin was present only in the tumor cells adjacent to the overlying hyperplastic squamous epithelium ❚Image 1B❚. In 4 more cases, the tumor cells adjacent to the overlying hyperplastic squamous epithelium were stained more strongly than tumor cells elsewhere. Altogether, we observed enhanced staining in tumor cells adjacent to hyperplastic epithelium in 9 of 13 cases with pseudoepitheliomatous hyperplasia. In the remaining 4 cases, 2 showed diffuse strong and 2 diffuse moderate staining in all tumor cells. The 9 cases with enhanced staining were from the following sites: skin, 4; tongue, 3; vulva, 1; and esophagus, 1. The effect of enhanced staining for calretinin was not observed in cases without pseudoepitheliomatous hyperplasia. S-100 protein and the alpha-subunit of inhibin did not show this effect.
Discussion
Calretinin is a 29-kd, calcium-binding protein belonging to the family of E-F hand proteins that includes S-100. The E-F hand proteins are characterized by a helix-loop-helix structure, which functions as the calcium-binding site. 13 Calretinin is expressed primarily in certain subtypes of neurons in the central and peripheral nervous systems. 13 Extraneuronal expression of calretinin is much less understood. In 1996, Doglioni et al 14 demonstrated that calretinin was expressed in human mesothelial cells and mesothelioma. Since that report, other studies have lent further support to the usefulness of calretinin in immunohistochemical analysis for the differential diagnosis between mesothelioma and adenocarcinoma. 15, 16 The presence of calretinin has been shown in human ovarian surface epithelial cells, theca interna cells, stromal cells, hilar cells, and certain types of ovarian sex cord-stromal tumors. [17] [18] [19] Inhibin is a polypeptide hormone consisting of 2 subunits, 1 alpha and 1 beta. It is secreted primarily by ovarian granulosa cells and testicular Sertoli cells and serves as an inhibitor of follicle-stimulating hormone emanating from the pituitary gland. [20] [21] [22] [23] The alphasubunit also is expressed in placenta, adrenal gland, and pituitary in addition to gonads. Studies have found that the alpha-subunit of inhibin is a useful marker for ovarian sex cord-stromal tumors 24, 25 and adrenocortical neoplasms. 26, 27 Doglioni et al, 14 in their study of calretinin expression in mesotheliomas, found 3 cases of GCT that also stained positively. Mangini et al, 28 in a study of mast cell lesions of the skin, found similar results in 4 cases of GCT. Recently, Murakata and Ishak 29 demonstrated that the alpha-subunit of inhibin was expressed in all 17 cases of GCT from the gallbladder and extrahepatic bile ducts that they studied. Our results showed that GCTs from different sites all were positive for the alpha-subunit of inhibin and most of them (40/43 [93%]) for calretinin, strongly suggesting the usefulness of these 2 markers in the differential diagnosis in these tumors.
However, further studies on their expression in other lesions that mimic GCTs are necessary to determine whether they are superior markers to S-100 protein. The presence of inhibin and calretinin in granular cell tumors also widens the spectrum of lesions detected by these antibodies.
The histogenesis of GCTs has been a source of debate since the first description by Abrikossoff 2 in 1926. Early theory proposed muscle or myoblastic origin based on their histologic similarity to degenerating skeletal muscle or embryonic striated muscle cells and the close relationship between the tumor cells and skeletal muscle fibers. [2] [3] [4] However, this theory was replaced by the theory of neural origin. Frequently it has been found that GCTs are associated closely with peripheral nerves, where the tumor cells are present within or surround nerve bundles and ganglions. 7, 30, 31 Ultrastructural studies have demonstrated the presence of autophagic lysosomes with myelin-like figures, axon-like A B C ❚Image 2❚ Immunohistochemical staining of granular cell tumors (A, S-100 protein, ×200; B, alpha-subunit of inhibin, ×200; C, calretinin, ×200). S-100 and calretinin stained both the nuclei and cytoplasm, while the alpha-subunit of inhibin stained only the cytoplasm.
structures, cell processes, and basal laminae and the absence of glycogen. 6, 9 Immunohistochemically, the tumor cells react with S-100 protein, neuron-specific enolase, myelin basic proteins, laminin, Leu 7, and PGP 9.5. 5, [8] [9] [10] [11] [12] Based on these findings, many authors believe that GCTs are indeed derived from Schwann cells. Since calretinin typically is expressed in neurons and ganglion cells, its presence in GCTs further supports a neural origin or differentiation for these tumors. Although calretinin has not been reported to be present in Schwann cells, we have observed that schwannomas frequently are positive for calretinin (unpublished data), further supporting this hypothesis. Pseudoepitheliomatous hyperplasia is a well-recognized feature associated with GCTs in which the squamous epithelium, either skin or mucosa, overlying the tumor cells is markedly hyperplastic. 1 The mechanism responsible for these changes is poorly understood. Thirteen of our cases from skin and squamous mucosa showed pseudoepitheliomatous hyperplasia. In 9 of these cases, calretinin positivity was increased in the tumor cells adjacent to the hyperplastic squamous epithelium. These findings suggest a role for calretinin in the interaction between the squamous epithelium and the tumor cells.
We have shown that the alpha-subunit of inhibin and calretinin, in addition to S-100 protein, are useful diagnostic markers for GCTs. In addition, the presence of calretinin further supports a neural origin or differentiation for these tumors. Understanding the role of calretinin in the interaction between the tumor cells and hyperplastic squamous epithelium requires further study.
